linkedin post 2013-06-16 06:59:11

COMPULSORY LICENSES in China and India are evolving, but appear to be following the path of making a drug innovator grant patent licenses to generic drug makers. How this plays out will cast the landscape for pharmaceutical markets for 2.5 billion consumers in a planet of 7 billion.

http://www.millercanfield.com/publications-articles-321.html?goback=.gde_4513133_member_249734556

View in LinkedIn